NewHydrogen, Inc.
NewHydrogen, Inc. is a U.S.-based clean energy technology developer focused on thermochemical green hydrogen production. The company is developing ThermoLoop™ with research support at UC Santa Barbara, and it has also previously worked on material technology for photovoltaic solar modules.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueDevelopment of ThermoLoop™ and related water-splitting systems for low-cost green hydrogen production.
Research and development work tied to materials, process design, and prototype advancement.
Earlier-stage photovoltaic material technology aimed at improving solar module economics.
Customers
NewHydrogen is primarily a development-stage company, so its direct customer base is limited and not yet commercialized. Its economic stakeholders are likely to include future hydrogen buyers, industrial energy users, and strategic partners that would adopt or license its technology if it reaches commercialization. The company also relies on investors as a funding source while it advances the technology.
Potential buyers of low-cost green hydrogen for fertilizers, refining, steel, and chemicals.
Companies that may collaborate on development, pilot deployment, or commercialization of ThermoLoop™.
University and lab partners that help test materials and validate the technology.
Equity investors that fund ongoing R&D and corporate overhead before revenue generation.
Strategy
The company’s near-term strategy is to preserve and advance the ThermoLoop™ development program while managing cash carefully. It is also seeking additional capital from existing and new investors to support prototyping and continued R&D. Longer term, the strategy is to commercialize a lower-cost hydrogen production pathway that can compete with electrolyzer-based green hydrogen.
The company’s value proposition depends on proving the technology can produce hydrogen at lower cost.
The company needs capital to fund R&D and general corporate expenses before revenue generation.
Commercial adoption is needed to convert the technology platform into a sustainable business.
Geography
The company is based in the United States and operates from Los Angeles, California. Its current development work is tied to UC Santa Barbara, also in California, which makes its operating footprint concentrated in the U.S. Because the technology targets global hydrogen markets, its eventual commercial opportunity is international even though current operations are domestic.
Risks
The company is pre-revenue and depends on external financing to continue operations, which creates substantial going-concern risk. Its business also depends on technical success in developing ThermoLoop™ and on eventual market acceptance of a new hydrogen production method. As with many early-stage clean technology developers, execution, funding availability, and valuation of equity-linked instruments are key risks.
The company has not generated revenue and expects to need additional capital to fund operations.
Exposure: Corporate liquidity and continuity of operations
ThermoLoop™ is still in development, so technical feasibility, scale-up, and cost targets remain uncertain.
Exposure: R&D program and future commercialization
Management expects to fund the business through securities issuance, which can dilute existing holders.
Exposure: Shareholder value and capital structure
Even if the technology works, customers may prefer established hydrogen production methods.
Exposure: Commercialization and revenue conversion
Fair value estimates for stock options and derivative liabilities can be volatile and judgmental.
Exposure: Reported earnings and balance sheet values
Accounting
Judgemental itemsValuation depends on market price, volatility, interest rates, and conversion assumptions, which can materially change reported expense.
Impact: Can create volatile non-cash gains or losses
Development-stage assets may need write-downs if expected future cash flows do not support carrying value.
Impact: Could reduce asset values and increase losses
Future tax benefits are uncertain without sustained taxable income.
Impact: Affects net deferred tax assets and tax expense
Liquidity assumptions and financing plans are central to the financial statement basis of preparation.
Impact: Important for assessing solvency and continuity
Similar listed companies
Publicly listed companies with a comparable business focus.
Sunhydrogen, Inc.
HYSR · Semiconductors & Related Devices
Thermon Group Holdings, Inc.
Electrical Industrial Apparatus
Turbogen Ltd.
TRBG · Electric & Other Services Combined
Green Planet Bio Engineering Co. Ltd.
GPLB · Biological Products, (No Diagnostic Substances)
Green Planet Bio Engineering Co.
Terra Innovatum Global N.V.
NKLR · Fabricated Plate Work (Boiler Shops)
Niagen Bioscience, Inc.
NAGE · Medicinal Chemicals & Botanical Products
Last updated: 24/09/2026